Cargando…
Harnessing the integrated stress response for the treatment of multiple sclerosis
Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease of the central nervous system (CNS) with no known cure. Though a dozen immunomodulatory therapies exist, their impact on progression of disease appears limited. The field has hence focused on alternate strategies for treatment suc...
Autores principales: | Way, Sharon W., Popko, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792730/ https://www.ncbi.nlm.nih.gov/pubmed/26873788 http://dx.doi.org/10.1016/S1474-4422(15)00381-6 |
Ejemplares similares
-
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic
por: Way, Sharon W., et al.
Publicado: (2015) -
Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014) -
Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis
por: Junior, Markley Silva Oliveira, et al.
Publicado: (2023) -
Prolonging the integrated stress response enhances CNS remyelination in an inflammatory environment
por: Chen, Yanan, et al.
Publicado: (2021) -
Insights into the mechanism of oligodendrocyte protection and remyelination enhancement by the integrated stress response
por: Chen, Yanan, et al.
Publicado: (2023)